2001-April Archives by Date
Starting: Mon Apr 2 06:52:01 2001
Ending: Mon Apr 30 19:16:01 2001
Messages: 112
- [Pharm-policy] Brazil-Merck agreement
Fatima Suleman
- [Pharm-policy] Blair sides with drug giants
Alan Story
- [Pharm-policy] Bulk Procurement and Distribution System
Paul Davis
- [Pharm-policy] Patents in Africa - Abacavir, 3TC, AZT and Nevirapine
James Love
- [Pharm-policy] German news magazine FOCUS 02/04/2001 report on research in dev countries, drug pricing, SA court case
Prof. Udo Schuklenk
- [Pharm-policy] Re: do patents matter in Africa?
msmith@Oxfam.org.uk
- [Pharm-policy] TAC letter of U. of Minnesota on Ziagen
Mike Palmedo
- [Pharm-policy] MSF proposal on not for profit drug company
James Love
- [Pharm-policy] PhRMA report on sales abroad
James Love
- [Pharm-policy] MSF proposal on not for profit drug company
Susan Finston
- [Ip-health] Re: [Pharm-policy] MSF proposal on not for profit drug company
Alan Story
- [Ip-health] Re: [Pharm-policy] MSF proposal on not for profit drug company
Alan Story
- [Ip-health] Re: [Pharm-policy] MSF proposal on not for
profit drug company
Susan Finston
- [Pharm-policy] PHRMA speaks
George M. Carter
- [Pharm-policy] Reuters on SA PMA Affidavit
Mike Palmedo
- [Pharm-policy] Perspectives on Harvard Proposal
Paul Davis
- [Ip-health] Re: [Pharm-policy] MSF proposal on not for
profit drug company
Susan Finston
- [Pharm-policy] Susan/ad hominem attack?
George M. Carter
- [Pharm-policy] Implementation of Antiretroviral Therapy in the Developing World:
Brazil and Beyond
Gonsalves, Gregg
- [Ip-health] Re: [Pharm-policy] MSF proposal on not for profit drug company
Alan Story
- [Ip-health] Re: [Pharm-policy] MSF proposal on not forprofit drug company
Alan Story
- [Ip-health] Re: [Pharm-policy] MSF proposal on not forprofit drug company
Alan Story
- [Pharm-policy] NIH vs. Pharma was: MSF proposal on not forprofit drug company
Gonsalves, Gregg
- [Pharm-policy] Re: NIH vs. Pharma was: MSF proposal on not forprofit drug company
Dean Baker
- [Pharm-policy] Sanders letter to World Bank on IPR (fwd)
Robert Weissman
- [Pharm-policy] query: IMF/WB and IP issues relating to AIDS treatment
Robert Naiman
- [Pharm-policy] $1 billion on for AIDS on table tonight in DC.
Paul Davis
- [Pharm-policy] Re: Remove-- Cancel subscription
Sydney Lewis
- [Pharm-policy] Technology Transfer Forum April 17-18
James Love
- [Pharm-policy] Firms spent $7.7 million on clinical research per orphan drug approval
in 1997
James Love
- [Pharm-policy] Re: Disturbed
Alan Story
- [Ip-health] Re: [Pharm-policy] MSF proposal on not for profit drug
company
Els Torreele
- [Pharm-policy] Re: NIH vs. Pharma was: MSF proposal on not forprofit drug company
Alan Story
- [Pharm-policy] Re: [Ip-health] Frist Amendment
Lyndamdee@aol.com
- [Pharm-policy] Rockefeller Foundation Press Release
Mike Palmedo
- [Pharm-policy] BBC on Norway meeting
James Love
- [Pharm-policy] Glaxo refuses to cut HIV drug prices more than 90%
James Love
- [Pharm-policy] Ramsey pricing
James Love
- [Pharm-policy] Aharonian: Gene Patents, MTAs, Generics; Zoloft; Taxol; Canada TRIPS
James Love
- [Pharm-policy] Various Norway talking points
James Love
- [Pharm-policy] Mali accepts 5-company initiative
Robert Weissman
- [Pharm-policy] To Fight AIDS, Use Both Treatment and Prevention
Gonsalves, Gregg
- [Pharm-policy] Norway: How to help the poor, really (and how not to)
James Love
- [Pharm-policy] New WTO Press Release on Norway Meeting
Mike Palmedo
- [Pharm-policy] TAC Submits Affidavit
James Love
- [Pharm-policy] Press Release: AIDS and New Trade Agreements
Paul Davis
- [Pharm-policy] Affidavit in the South Africa court case
James Love
- [Pharm-policy] Costs of HIV drug clinical trials cited in NDA
James Love
- [Pharm-policy] Sachs and Danzon at the Hosbjor meeting
James Love
- [Pharm-policy] Proposed TACD resolution on access to health care
James Love
- [Pharm-policy] Sachs, me and Haddad
James Love
- [Pharm-policy] Goozner in Slate on Andrew Sullivan and big pharma
James Love
- [Pharm-policy] Kremer and Glennerster in Cato on purchase fund
James Love
- [Pharm-policy] expanded access program
James Love
- [Pharm-policy] Bush nominated Heimbold Sweden ambassador
James Love
- [Pharm-policy] Ivory Coast to import generic AIDS drugs
James Love
- [Pharm-policy] NPR Lies Again
George M. Carter
- [Pharm-policy] Cipla starts $1-a-day AIDS drugs exports
Mike Palmedo
- [Pharm-policy] Pharmacists appeal for solution to drugs (South Africa) 4/18/01
steph
- [Pharm-policy] SA court case
James Love
- [Pharm-policy] CPT/Essential Action: Response on SA Case
Robert Weissman
- [Pharm-policy] Drug firms lose first battle in long and costly war
Mike Palmedo
- [Pharm-policy] Flawed analysis?
George M. Carter
- [Pharm-policy] MSF, TAC, Oxfam press release-SAfrica court case
ACCESS-Com
- [Pharm-policy] Uganda Urges Compensation for AIDS Research Costs
Mike Palmedo
- [Pharm-policy] U supports reducing price of Ziagen
Steph Kerimo
- [Pharm-policy] Re: [Ip-health] Uganda Urges Compensation for AIDS Research Costs
Gregg Gonsalves
- [Pharm-policy] NY Times: Despite Legal Victory, South Africa Hesitates on AIDS Drugs
Mike Palmedo
- [Pharm-policy] Salon.com: The drug companies' racket
Mike Palmedo
- [Pharm-policy] query- india patents
tom sebastian
- [Pharm-policy] Napster wants compulsory Net-licenses for music catalogs
James Love
- [Pharm-policy] Congress of Americas and Brazil drug case
Rob Lake
- [Pharm-policy] Congress of Americas and Brazil drug case
George M. Carter
- [Pharm-policy] Prices of ddi, d4T and Combivir in South Africa pharmacies
James Love
- [Pharm-policy] Congress of Americas and Brazil drug case
Joel Lexchin
- [Pharm-policy] How much $ to save 25 million lives?
Robert Naiman
- [Pharm-policy] Mbeki and Economics
Negar Azimi
- [Pharm-policy] Brazilian UN Human Rights resolution passes 52,0 with 1 (USA) abstention
James Love
- [Pharm-policy] Mbeki and Economics
Fatima Suleman
- [Pharm-policy] Gardiner Harris: AIDS Gaffes in Africa Come Back to Haunt Drug Industry
at home
James Love
- [Pharm-policy] States forming own drug programs
Dean Hughson
- [Pharm-policy] Merck meeting in Adobe
Alacran7@aol.com
- [Pharm-policy] Global AIDS Strategy May Prove Elusive: Washington Post Article
Gonsalves, Gregg
- [Pharm-policy] Brazil, Roche & nelfinavir
Paul Davis
- [Pharm-policy] Geffen on BMS, ddi and d4t
James Love
- [Pharm-policy] Brazilian Drug Resolution Draws U.S. Criticism as IP Rights Threat
James Love
- [Pharm-policy] Brazilian Drug Resolution Draws U.S. Criticism as IP Rights Threat
James Love
- [Pharm-policy] AFP: Indian firms see bounty in cheap anti-AIDS drugs
Mike Palmedo
- [Pharm-policy] WP: Powell declines invitation to AIDS summit
Mike Palmedo
- [Pharm-policy] Important Kofi Anan Speech Today
Paul Davis
- [Pharm-policy] U.S./Brazil trade dispute
Michael Manoochehri
- [Pharm-policy] Phila Inquirer: Annan urges Africans to fight AIDS
Paul Davis
- [Pharm-policy] Powell Letter
Paul Davis
- [Pharm-policy] CNN: Brazil pushes AIDS fight Beyond Borders
Mike Palmedo
- [Pharm-policy] Boston Globe: Nigeria reaches deal with Indian firm to buy AIDS drugs
Mike Palmedo
- [Pharm-policy] Next steps against AIDS
Gonsalves, Gregg
- [Pharm-policy] [Ip-health] WSJ: Brazil Makes Name for Itself Pumping Out Cheap AIDS Drugs
Mike Palmedo
- [Pharm-policy] PBS NewsHour on AIDS in Africa
Gonsalves, Gregg
- [Pharm-policy] [Ip-health] WSJ: Brazil Makes Name for Itself Pumping Out Cheap AIDS Drugs
Mike Palmedo
- [Pharm-policy] African Leaders Back Less Costly AIDS Drugs,More Spending
James Love
- [Pharm-policy] [Ip-health] Friedman op-ed in NY Times
Mike Palmedo
- [Pharm-policy] [Ip-health] WP: Renamed Prozac Fuels Womens's Health Debate
Mike Palmedo
- [Pharm-policy] Re: [Ip-health] Friedman op-ed in NY Times
Prof. Udo Schuklenk
- [Pharm-policy] [Ip-health] ToC Developing World Bioethics
Prof. Udo Schuklenk
- [Pharm-policy] [Ip-health] Abuja Declaration on HIV/AIDS, TB and Other Related Infectious Diseases
Mike Palmedo
- [Pharm-policy] [Ip-health] could securities tax fund anti-AIDS efforts?
Robert Naiman
- [Pharm-policy] [Ip-health] Abuja Declaration on HIV/AIDS, TB and Other Related Infectious Diseases
Mike Palmedo
- [Pharm-policy] [Ip-health] could securities tax fund anti-AIDS efforts?
Robert Naiman
- [Pharm-policy] [Ip-health] WP: Renamed Prozac Fuels Womens's Health Debate
Mike Palmedo
- [Pharm-policy] [Ip-health] Friedman op-ed in NY Times
Mike Palmedo
- [Pharm-policy] Re: [Ip-health] Friedman op-ed in NY Times
Prof. Udo Schuklenk
- [Pharm-policy] [Ip-health] ToC Developing World Bioethics
Prof. Udo Schuklenk
Last message date:
Mon Apr 30 19:16:01 2001
Archived on: Mon Apr 30 18:16:02 2001
This archive was generated by
Pipermail 0.05 (Mailman edition).